A Comparison Between Co-phenylcaine Nasal Spray and Nasal Nebulization Prior to Rigid Nasoendoscopic Examination

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

May 13, 2016

Primary Completion Date

March 1, 2018

Study Completion Date

August 1, 2018

Conditions
AnaesthesiaRhinitis
Interventions
DEVICE

Nasal nebulisation into the right nostril

400mcl of co-phenylcaine (20mg of lidocaine + 2mg of phenylephrine) is added into the nasal nebuliser device (Rinowash Nebula, Air liquid medical systems) and the solution is diluted with 4.5cc of isotonic normal saline. This Mixture is then nebulised into the right nasal cavity for approximately 3 minutes.The seated patient's head is kept flexed and nebulizer device is kept sealed within the nasal cavity while the nebulisation is done and subsequently checking nasal resistance after nasal nebulisation.

DEVICE

Nasal Spray into the right nostril

Intervention : Administration of 4 sprays of nasal decongestions(Co-Phenylcaine(400mcl) (20mg lidocaine + 2mg phenylephrine) once into the right nasal cavity using a nasal spray and subsequently checking nasal resistance post nasal spray

Trial Locations (2)

41200

Hospital Tengku Ampuan rahimah, Klang

50603

University of Malaya Medical center, Kuala Lumpur

All Listed Sponsors
lead

University of Malaya

OTHER

NCT03380715 - A Comparison Between Co-phenylcaine Nasal Spray and Nasal Nebulization Prior to Rigid Nasoendoscopic Examination | Biotech Hunter | Biotech Hunter